JFL Life Sciences Limited (NSE:JFLLIFE)
10.35
+0.45 (4.55%)
At close: Sep 25, 2026
JFL Life Sciences Revenue
JFL Life Sciences had revenue of 111.02M INR in the quarter ending June 30, 2026, a decrease of -4.17%. This brings the company's revenue in the last twelve months to 1.31B, up 55.68% year-over-year. In the fiscal year ending March 31, 2026, JFL Life Sciences had annual revenue of 1.31B with 60.15% growth.
Revenue (ttm)
1.31B
Revenue Growth
+55.68%
P/S Ratio
0.26
Revenue / Employee
n/a
Employees
n/a
Market Cap
341.50M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.31B | 493.45M | 60.15% |
| Mar 31, 2025 | 820.42M | 350.23M | 74.49% |
| Mar 31, 2024 | 470.19M | 28.09M | 6.35% |
| Mar 31, 2023 | 442.10M | 99.00M | 28.85% |
| Mar 31, 2022 | 343.10M | 15.40M | 4.70% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Murae Organisor | 8.59B |
| Welcure Drugs and Pharmaceuticals | 3.66B |
| Mangalam Drugs & Organics | 2.32B |
| Rajnish Wellness | 1.68B |
| Deccan Health Care | 818.34M |
| Walpar Nutritions | 757.46M |
| Sandu Pharmaceuticals | 696.24M |
| Panjon | 492.78M |